Vicarious Surgical Inc (NYSE:RBOT) Short Interest Update

Vicarious Surgical Inc (NYSE:RBOTGet Free Report) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 65,800 shares, a decline of 28.9% from the October 15th total of 92,600 shares. Based on an average trading volume of 18,600 shares, the days-to-cover ratio is currently 3.5 days.

Vicarious Surgical Stock Up 15.0 %

RBOT traded up $1.37 during trading hours on Thursday, reaching $10.52. 60,459 shares of the company’s stock traded hands, compared to its average volume of 25,947. The firm has a market capitalization of $62.07 million, a PE ratio of -0.97 and a beta of 1.02. Vicarious Surgical has a 52-week low of $4.27 and a 52-week high of $21.43. The firm has a 50-day moving average price of $6.95 and a 200 day moving average price of $7.64.

Vicarious Surgical (NYSE:RBOTGet Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported ($2.86) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.98) by $0.12. Equities analysts predict that Vicarious Surgical will post -10.07 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Piper Sandler cut their price objective on shares of Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating on the stock in a research report on Wednesday.

Check Out Our Latest Analysis on Vicarious Surgical

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Recommended Stories

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.